Lehrstuhl für Allgemein- und Viszeralchirurgie

CRISPR-Cas9 Screen Identifies DYRK1A as a Target for Radiotherapy Sensitization in Pancreatic Cancer (2022) Lan B, Zeng S, Zhang S, Ren X, Xing Y, Kutschick I, Pfeffer S, et al. Journal article Neutrophil extracellular traps drive epithelial‐mesenchymal transition of human colon cancer (2021) Stehr A, Wang G, Demmler R, Stemmler M, Straube J, Tripal P, Schmid B, et al. Journal article, Original article The outcome of patients with inflammatory bowel disease-associated colorectal cancer is not worse than that of patients with sporadic colorectal cancer-a matched-pair analysis of survival (2021) Vitali F, Wein A, Rath T, Eckstein M, Neufert C, Siebler J, Atreya R, et al. Journal article Novel criteria for intratumoral budding with prognostic relevance for colon cancer and its histological subtypes (2021) Pour Farid P, Eckstein M, Merkel S, Grützmann R, Hartmann A, Bruns V, Benz M, et al. Journal article Collateral effects of the SARS-CoV-2 pandemic on oncologic surgery in Bavaria (2021) Dienemann T, Brennfleck F, Dejaco A, Grützmann R, Binder J, Krautz C, Stoess C, et al. Journal article Microfluidics applications for high-throughput single cell sequencing (2021) Zhou WM, Yan YY, Guo QR, Ji H, Wang H, Xu TT, Makabel B, et al. Journal article, Review article Interleukin-3 is a predictive marker for severity and outcome during SARS-CoV-2 infections (2021) Bénard A, Jacobsen A, Brunner M, Krautz C, Klösch B, Swierzy I, Naschberger E, et al. Journal article Indications for the surgical management of pancreatic neoplasms (2021) Brunner M, Belyaev O, Boesch F, Keck T, Witzigmann H, Grützmann R, Uhl W, Werner J Journal article, Review article Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Patients With Locally Advanced Rectal Cancer Long-term Results of the CAO/ARO/AIO-12 Randomized Clinical Trial (2021) Fokas E, Schlenska-Lange A, Polat B, Klautke G, Grabenbauer GG, Fietkau R, Kuhnt T, et al. Journal article Context Matters—Why We Need to Change From a One Size Fits all Approach to Made-to-Measure Therapies for Individual Patients With Pancreatic Cancer (2021) Sankarasubramanian S, Pfohl U, Regenbrecht CRA, Reinhard C, Wedeken L Journal article, Review article